GNRC vs PCRX · P/E 82, rev $1.17B vs P/E 174, rev $369.8M
Generac Holdings Inc (GNRC) versus Pacira BioSciences, Inc. (PCRX) — a side-by-side from cached financials, not a winner call.
Generac Holdings Inc (GNRC) is a specialty industrial machinery company listed on US.
Pacira BioSciences, Inc. (PCRX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported GNRC revenue for 2026-06-30 was $1.17B. Net income was $143.2M. Revenue was up 10.8% from 2026-03-31 to 2026-06-30. GNRC currently screens at market cap $15.40B and trailing P/E 82.0.
Latest reported PCRX revenue for 2026-06-30 was $369.8M. Net income was $7.6M. PCRX currently screens at market cap $890.8M and trailing P/E 174.2.
GNRC currently screens at market cap $15.40B and trailing P/E 82.0. PCRX currently screens at market cap $890.8M and trailing P/E 174.2.
Not investment advice. Open the GNRC and PCRX stock pages for the full models.
Not investment advice.